Each of these experimental vaccines has already shown promise in
smaller trials designed to flag any serious safety concerns and show
whether candidates can spur some response from the immune system.
Early safety data is key; unlike drugs, vaccines are typically given
to relatively healthy people and shouldn't create severe risks.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/covid-vaccine-frontrunners-will-face-their-moment-of-truth-this-month-itself/articleshow/77903886.cms
No comments:
Post a Comment